Company Profile
Monarch Lifesciences
Proteomics
Diagnostics
Service
|
351 West 10th Street Indianapolis, IN 46202 USA www.monarchlifesciences.com |
Incorporated in 2004 16 Employees |
Privately Held |
|
This Year's Highlights Not Provided |
Anticipated Highlights Not Provided |
|
Corporate Mission Monarch LifeSciences has developed advanced proteomics technologies which confidently identify candidate protein biomarkers from minimal sample volumes and enable development of fully quantitative assays in as little as four weeks without the need for antibodies. Utilizing unique sample preparation methods, novel mass spectrometry techniques, comprehensive biostatistics, and proven expertise with diverse biological samples, Monarch LifeSciences can discover, develop, and validate protein biomarkers for use in preclinical and clinical assays. These sensitive and selective assays can be leveraged to evaluate efficacy, toxicity, stratify patient populations, develop companion diagnostics, corroborate genomic results, and enrich clinical trial data. We seek partners and investors for market growth as well as clients who wish to develop competitive advantage in the area of biomarker use.While some groups offer only one format, instrument platform, or methodology, Monarch LifeSciences has developed expertise in diverse protein separation and mass spectrometry technologies. Our objective is to engage the best technology to solve our customer?s problems. |